Global Artificial Blood Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Artificial Blood Revenue
• 1.4 Market by Type
  • 1.4.1 Global Artificial Blood Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Human Blood
  • 1.4.3 Synthetic Blood
  • 1.4.4 Animal Blood
• 1.5 Market by Application
  • 1.5.1 Global Artificial Blood Market Share by Application: 2020 VS 2026
  • 1.5.2 Hemoglobin-Based Oxygen Carriers (HBOCs)
  • 1.5.3 Perflurocarbon Emulsions (PFCEs)
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Artificial Blood Market Perspective (2015-2026)
• 2.2 Global Artificial Blood Growth Trends by Regions
  • 2.2.1 Artificial Blood Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Artificial Blood Historic Market Share by Regions (2015-2020)
  • 2.2.3 Artificial Blood Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Artificial Blood Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Artificial Blood Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Artificial Blood Players by Market Size
  • 3.1.1 Global Top Artificial Blood Players by Revenue (2015-2020)
  • 3.1.2 Global Artificial Blood Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Artificial Blood Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Artificial Blood Market Concentration Ratio
  • 3.2.1 Global Artificial Blood Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Artificial Blood Revenue in 2019
• 3.3 Artificial Blood Key Players Head office and Area Served
• 3.4 Key Players Artificial Blood Product Solution and Service
• 3.5 Date of Enter into Artificial Blood Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Artificial Blood Historic Market Size by Type (2015-2020)
• 4.2 Global Artificial Blood Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Artificial Blood Market Size by Application (2015-2020)
• 5.2 Global Artificial Blood Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Artificial Blood Market Size (2015-2020)
• 6.2 Artificial Blood Key Players in North America (2019-2020)
• 6.3 North America Artificial Blood Market Size by Type (2015-2020)
• 6.4 North America Artificial Blood Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Artificial Blood Market Size (2015-2020)
• 7.2 Artificial Blood Key Players in Europe (2019-2020)
• 7.3 Europe Artificial Blood Market Size by Type (2015-2020)
• 7.4 Europe Artificial Blood Market Size by Application (2015-2020)

8 China

• 8.1 China Artificial Blood Market Size (2015-2020)
• 8.2 Artificial Blood Key Players in China (2019-2020)
• 8.3 China Artificial Blood Market Size by Type (2015-2020)
• 8.4 China Artificial Blood Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Artificial Blood Market Size (2015-2020)
• 9.2 Artificial Blood Key Players in Japan (2019-2020)
• 9.3 Japan Artificial Blood Market Size by Type (2015-2020)
• 9.4 Japan Artificial Blood Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Artificial Blood Market Size (2015-2020)
• 10.2 Artificial Blood Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Artificial Blood Market Size by Type (2015-2020)
• 10.4 Southeast Asia Artificial Blood Market Size by Application (2015-2020)

11 India

• 11.1 India Artificial Blood Market Size (2015-2020)
• 11.2 Artificial Blood Key Players in India (2019-2020)
• 11.3 India Artificial Blood Market Size by Type (2015-2020)
• 11.4 India Artificial Blood Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Artificial Blood Market Size (2015-2020)
• 12.2 Artificial Blood Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Artificial Blood Market Size by Type (2015-2020)
• 12.4 Central & South America Artificial Blood Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Dextro-Sang Corporation
  • 13.1.1 Dextro-Sang Corporation Company Details
  • 13.1.2 Dextro-Sang Corporation Business Overview
  • 13.1.3 Dextro-Sang Corporation Artificial Blood Introduction
  • 13.1.4 Dextro-Sang Corporation Revenue in Artificial Blood Business (2015-2020))
  • 13.1.5 Dextro-Sang Corporation Recent Development
• 13.2 BioPure Corporation
  • 13.2.1 BioPure Corporation Company Details
  • 13.2.2 BioPure Corporation Business Overview
  • 13.2.3 BioPure Corporation Artificial Blood Introduction
  • 13.2.4 BioPure Corporation Revenue in Artificial Blood Business (2015-2020)
  • 13.2.5 BioPure Corporation Recent Development
• 13.3 Sangart
  • 13.3.1 Sangart Company Details
  • 13.3.2 Sangart Business Overview
  • 13.3.3 Sangart Artificial Blood Introduction
  • 13.3.4 Sangart Revenue in Artificial Blood Business (2015-2020)
  • 13.3.5 Sangart Recent Development
• 13.4 Northfield Laboratories
  • 13.4.1 Northfield Laboratories Company Details
  • 13.4.2 Northfield Laboratories Business Overview
  • 13.4.3 Northfield Laboratories Artificial Blood Introduction
  • 13.4.4 Northfield Laboratories Revenue in Artificial Blood Business (2015-2020)
  • 13.4.5 Northfield Laboratories Recent Development
• 13.5 Baxter International
  • 13.5.1 Baxter International Company Details
  • 13.5.2 Baxter International Business Overview
  • 13.5.3 Baxter International Artificial Blood Introduction
  • 13.5.4 Baxter International Revenue in Artificial Blood Business (2015-2020)
  • 13.5.5 Baxter International Recent Development
• 13.6 Dentritech
  • 13.6.1 Dentritech Company Details
  • 13.6.2 Dentritech Business Overview
  • 13.6.3 Dentritech Artificial Blood Introduction
  • 13.6.4 Dentritech Revenue in Artificial Blood Business (2015-2020)
  • 13.6.5 Dentritech Recent Development
• 13.7 FluorO2 Therapeutics
  • 13.7.1 FluorO2 Therapeutics Company Details
  • 13.7.2 FluorO2 Therapeutics Business Overview
  • 13.7.3 FluorO2 Therapeutics Artificial Blood Introduction
  • 13.7.4 FluorO2 Therapeutics Revenue in Artificial Blood Business (2015-2020)
  • 13.7.5 FluorO2 Therapeutics Recent Development
• 13.8 Nuvox Pharma
  • 13.8.1 Nuvox Pharma Company Details
  • 13.8.2 Nuvox Pharma Business Overview
  • 13.8.3 Nuvox Pharma Artificial Blood Introduction
  • 13.8.4 Nuvox Pharma Revenue in Artificial Blood Business (2015-2020)
  • 13.8.5 Nuvox Pharma Recent Development
• 13.9 Alpha Therapeutic Corporation
  • 13.9.1 Alpha Therapeutic Corporation Company Details
  • 13.9.2 Alpha Therapeutic Corporation Business Overview
  • 13.9.3 Alpha Therapeutic Corporation Artificial Blood Introduction
  • 13.9.4 Alpha Therapeutic Corporation Revenue in Artificial Blood Business (2015-2020)
  • 13.9.5 Alpha Therapeutic Corporation Recent Development
• 13.10 HemoBioTech
  • 13.10.1 HemoBioTech Company Details
  • 13.10.2 HemoBioTech Business Overview
  • 13.10.3 HemoBioTech Artificial Blood Introduction
  • 13.10.4 HemoBioTech Revenue in Artificial Blood Business (2015-2020)
  • 13.10.5 HemoBioTech Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer